TEL AVIV, Israel--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that its Chief Financial and Operating Officer, Philip Serlin, will be presenting at the JMP Securities annual life sciences equity research conference being held at the St. Regis Hotel in New York.
Help employers find you! Check out all the jobs and post your resume.
